HLB Life Science Co. Ltd (067630) — Capital Reinvestment Ratio
Latest as of March 2023:
0.99x
HLB Life Science Co. Ltd (067630) has a Capital Reinvestment Ratio of 0.99x as of March 2023, meaning it reinvests 1% of its operating cash flow (₩3.55 Billion) in capital expenditures (₩3.52 Billion). See HLB Life Science Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.99x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.55 Billion
KRW
Capital Expenditures
₩3.52 Billion
KRW
Data as of
Mar 2023
Most recent filing
HLB Life Science Co. Ltd Capital Reinvestment Ratio (2012–2020)
This chart tracks HLB Life Science Co. Ltd's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for HLB Life Science Co. Ltd (2012–2020)
Year-by-year Capital Reinvestment Ratio for HLB Life Science Co. Ltd from 2012 to 2020. For live market cap and broader valuation context, see 067630 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 4.18x | ₩2.01 Billion | ₩8.41 Billion | ▲ +18377.9% |
| 2014 | 0.02x | ₩10.43 Billion | ₩236.21 Million | ▲ +29.7% |
| 2013 | 0.02x | ₩2.95 Billion | ₩51.48 Million | ▼ -97.3% |
| 2012 | 0.66x | ₩13.97 Billion | ₩9.18 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow